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Objective: to compare the effectiveness of invasive therapy, supervised physical training and no treatment in terms of
health-related quality of life (HRQL) in patients with intermittent claudication (IC).
Design: a prospective, randomised, controlled study.
Materials: a total of 253 unselected patients with stable IC were sequentially randomised into 3 balanced treatment
groups. At 1 year follow-up data from a battery of generic and disease specific HRQL questionnaires, and global indices
of quality of life and physical condition were available in 171 patients.
Results: compared with a non-diseased reference group, claudicants were substantially limited in daily physical
functioning, but little affected regarding emotional, cognitive and social functioning, or well-being. Invasive therapy
yielded significantly greater improvements in some aspects of physical functioning and walk-related symptoms than
training. Training was not superior to invasive therapy on any HRQL dimension and superior to no treatment on only
one dimension. Treatment effects, however, were generally small-to-moderate and levels of physical dysfunction in all
groups remained higher than reference values.
Conclusions: invasive therapy is more effective than supervised training in alleviating illness-specific symptoms and
improving certain aspects of physical functioning – the primary HRQL domains impacted on by IC and the principal
goals of its treatment. However, since treatment effect sizes were at most moderate and given that untreated claudicants
reported at most small deterioration in HRQL, the level of evidence supporting invasive therapy is modest.
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Introduction tors,30 correlate poorly with patient-based assessments
of treatment benefit, evaluation instruments have
Intermittent claudicants experience moderate to severe recently been extended to include HRQL measures.
To date, only a handful of intermittent claudicationlimitation in walking capacity and physical activity
accompanied by substantial impairment in various (IC) studies have applied HRQL measures in eval-
uating treatment outcome.6–9,26,28,31,32 Of these, only aaspects of health-related quality of life (HRQL).1–11
Treatment aims principally at relieving claudication few have compared the relative impacts on HRQL
of different treatment modalities: surgery versussymptoms and improving physical functioning. To
this end, conservative management3,4,7,12–24 and invasive angioplasty versus unsupervised training,9 angio-
plasty versus no treatment27 and two forms oftherapies25–28 have both been shown to be effective.
Controversy exists, however, concerning the relative training versus no treatment.7 Results from these
studies showed significant improvements in physicaleffectiveness of these treatments.
Since conventional markers, such as treadmill functioning and/or pain following invasive therapy
and supervised training compared with unsupervisedwalking performance1,29 and other clinical indica-
training or no treatment, while other HRQL di-
mensions were unaffected. Direct comparisons of
∗ Please address all correspondence to: C. Taft, Health Care Research supervised training versus invasive therapy have notUnit, Institute of Internal Medicine, Sahlgrenska University Hospital,
SE-413 45 Go¨teborg, Sweden. been conducted and methodological differences in
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Concepts Instruments clinic at Sahlgrenska University Hospital and pre-
senting with symptoms of stable intermittent clau-Disease specific complaints Complaints score
• Walk dication for more than 6 months. Of these, the first
• Rest 253 were invited to complete the battery of HRQL
Functional health Sickness Impact Profile∗ questionnaires. Descriptions of the study protocol,Physical/mobility oriented • SIPIC
consequences • Ambulation randomization procedure, inclusion and exclusion cri-
• Overall teria, treatment procedures, patency and compliance
• Physical dimension rates, and patient clinical and demographic data are• Mobility
• Body care and movement provided in the companion article.34 Patients were
• Home management sequentially randomised to three balanced groups:
• Sleep and rest supervised physical training, invasive therapy and• Recreation and pastimes
• Work controls. Patients who changed treatment groups after
• Eating randomisation, were deemed unsuitable for inter-
Emotional/cognitive/social • Psychosocial dimension vention or discontinued training were analysed on anconsequences • Social interaction
• Alertness behaviour intention-to-treat basis.
• Emotional behaviour
General health perceptions GHRI-CH
Current health Global rating Study sample and dropoutsOverall physical condition
Mental health/well-being HAD
• Depression Of the original 253 patients at randomisation, 25 later
• Anxiety declined to participate in the HRQL study. Com-MACL
parisons between this group and the 228 remaining• Overall
Overall quality of life Global rating patients revealed no statistically significant differences
Life satisfaction Life satisfaction score in any of the clinical measures or demographic
variables.
Fig. 1. Continuum of health related quality of life concepts and Between baseline and follow-up 14 patients died, 3instruments from disease-specific to general well-being.
underwent amputation and 15 were lost to follow-up.• SIP=primary outcome measure.
Another 25 patients failed to complete all the HRQL
instruments and were excluded from data analyses.
At one-year follow-up, complete HRQL data werethese studies impede comparisons of the effectiveness
available for 171 patients (mean age=67, SD=3; 66%of treatments across trials.
males). Of these, 18 patients changed treatment groups,In this prospective, randomised, controlled study
but are included in the intention-to-treat analyses.we have applied a broad set of generic and disease-
Analyses of differences between the remaining groupspecific instruments to comprehensively describe,
of 171 and the attrition group (n=57) of baselineevaluate and compare a wide range of core HRQL
questionnaire data were significant (p<0.05) only fordimensions in stable IC patients across treatments.
SIP Sleep and rest, where worse scores were obtainedThe specific aim of this study was to assess the relative
in the attrition group.impacts of supervised training versus invasive therapy
versus non-treatment on different dimensions of clau-
dicants’ HRQL at one-year follow-up. In accordance Healthy reference group
with the health model proposed by Ware,33 we ex-
pected the impact of intermittent claudication and its An historical healthy reference group (n=89; mean
treatment to vary along a specific-to-general HRQL age=63, SD=7.6; 56% males), randomly selected from
continuum, from strong effects on disease-specific a population registry of the Go¨teborg region,35 was
symptom burden to weaker effects on overall per- used for comparisons with obtained HRQL values at
ceptions of quality of life and life satisfaction (see baseline and follow-up. None of the participants had
Fig. 1). diagnosed intermittent claudication or any severe
chronic illness.
HRQL assessment instrumentsPatients and Methods
At baseline and one year follow-up patients wereThe initial study sample comprised 264 unselected
patients referred to the vascular surgical outpatient administered an extensive battery of generic and
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study-specific questionnaires covering a wide spec- statements about health-related dysfunction in 12
trum of HRQL concepts. Figure 1 gives a schematic distinct categories of daily activities. Three categories
presentation of these concepts arranged along a con- are integrated to form a physical dimension and
tinuum ranging from disease-specific symptoms and four comprise a psychosocial dimension. The 12
complaints, through functional health, perceptions of categories combined form an overall SIP dimension.
current health and physical condition, mental health The SIP category Communication was omitted in
and well-being, to overall QoL and life satisfaction. this study.
Ths SIPIC scale,3 developed to assess levels of clau-
dication-specific dysfunction, comprises 12 items ex-Sickness Impact Profile (SIP)
tracted from the SIP categories Ambulation, HomeThe SIP is a behaviourally based measure of health
management, Social interaction, Mobility, Alertnessstatus shown to be a valid and reliable instrument
behaviour and Sleep and rest. Scores represent thefor assessing clinical change over time among treat-
ment and diagnostic groups.36–38 It consists of 136 sum of the number of dysfunction items endorsed.
Table 1. HRQL dimension means (standard deviation) in the control (n=57), physical training (n=61) and invasive therapy (n=53)
groups at baseline and at one-year follow-up.
Baseline Follow-up
Control Physical Invasive Control Physical Invasive
training therapy training therapy
Disease specific complaints
Walk 2.5 (0.7) 2.4 (0.7) 2.5 (0.7) 2 (0.7)a∗ 2.3 (0.7)a 1.9 (0.7)b
Rest 1.6 (0.5) 1.7 (0.6) 1.7 (0.7) 1 (0.5)a 1.6 (0.6)ab 1.5 (0.7)b
Functional healthy
Physical/mobility
SIPIC 3.2 (2.6) 3.0 (2.4) 3.2 (2.8) 3 (2.5)a 3.1 (2.7)a 2.2 (2.3)b
Ambulation 17.3 (11.5) 18.9 (11.6) 17.2 (12.2) 15 (11.8) 18.0 (13.2) 13.0 (13.3)
Overall 9.8 (9.3) 9.8 (7.8) 9.8 (8.0) 10 (8.5) 10.1 (8.7) 8.1 (8.2)
Physical index 8.4 (7.8) 8.7 (7.4) 8.4 (7.1) 7 (7.3) 9.9 (10.9) 7.1 (8.7)
Mobility 5.0 (12.4) 4.7 (10.7) 5.6 (10.7) 3 (8.9) 6.2 (13.1) 5.2 (11.0)
Body care and movement 2.9 (5.8) 2.5 (5.6) 2.3 (4.6) 4 (8.1) 5.5 (10.7) 3.0 (6.7)
Home management 9.0 (14.8) 7.5 (13.1) 8.5 (11.8) 8 (14.0) 10.33 (18.8) 9.2 (15.8)
Sleep and rest 11.2 (15.3) 12.8 (15.0) 13.9 (13.2) 16 (17.6)a 13.8 (17.6)ab 10.6 (11.9)b
Recreation and pastimes 18.3 (17.2) 23.4 (20.7) 21.3 (18.1) 20 (19.9)a 17.0 (17.8)b 15.5 (16.4)b
Work 20.2 (30.1) 20.0 (30.9) 22.0 (31.5) 20 (32.2) 19.36 (31.4) 14.9 (27.6)
Eating 2.0 (3.4) 1.6 (3.3) 1.6 (2.8) 1 (3.8) 1.45 (3.3) 1.5 (3.9)
Emotional/cognitive/social
Psychosocial index 7.5 (11.4) 5.4 (7.2) 5.2 (6.9) 7 (8.8) 6.6 (9.1) 5.3 (8.6)
Social interaction 7.2 (12.4) 5.7 (7.6) 6.5 (9.4) 7 (9.7) 6.3 (7.8) 6.2 (11.4)
Alertness behaviour 6.6 (14.3) 4.0 (9.5) 3.9 (7.9) 5 (11.4) 7.2 (14.4) 2.8 (7.3)
Emotional behaviour 8.8 (13.9) 6.5 (10.6) 5.1 (9.3) 9 (12.7) 6.2 (9.8) 6.8 (14.6)
Current health perceptions
Current health 2.7 (1.0) 2.8 (1.1) 2.6 (1.0) 2 (1.0)a 3.0 (1.0)ab 3.2 (1.1)b
Physical condition 4.4 (1.5) 4.6 (1.4) 4.4 (1.4) 4 (1.4) 5.1 (1.1) 5.1 (1.5)
Mental health/well-being
HAD Depression 4.4 (4.4) 3.4 (3.1) 4.1 (3.9) 4 (3.9) 3.3 (3.1) 4.0 (3.6)
HAD Anxiety 3.9 (4.2) 4.5 (4.2) 4.0 (3.9) 3 (3.8) 4.1 (3.9) 3.5 (3.9)
Overall mental well-being 3.2 (0.5) 3.3 (0.4) 3.3 (0.4) 3 (0.5) 3.2 (0.5) 3.2 (0.5)
Overall quality of life 4.6 (1.4) 4.9 (1.3) 4.7 (1.3) 4 (1.3) 5.2 (1.1) 5.3 (1.4)
Life satisfaction 3.3 (0.5) 3.4 (0.5) 3.2 (0.6) 3 (0.5) 3.4 (0.4) 3.3 (0.5)
∗Highlighted figures indicate significant between-group differences (Kruskal–Wallis non-parametric analysis of variance, p>0.05).
Means with same letters are not significantly different (Fisher’s permutation test, p>0.05).
Disease specific complaint scores range from 1–4, where higher indicate more complaints; all Functional health scores range from 0–100
(except SIPIC which ranges from 0–12), where higher scores indicate greater dysfunction; Current health scores range from 1–4, where
higher scores indicate better health; Physical condition scores range from 1–7, where higher scores indicate better condition; HAD scores
range from 0–21, where lower scores indicate less psychological distress; Overall mental well-being scores range from 1–4, where higher
scores indicate better well-being; Overall quality of life scores range from 1–7 where higher scores indicate better quality of life; Life
satisfaction scores range from 1–4, where higher scores indicate greater satisfaction.
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Fig. 2. Health related quality of life changes between baseline and follow-up for the three treatment procedures expressed as standardised
response means (SRM=mean change between assessments divided by the standard deviation of change: trivial <0.2; small [0.2 to <0.5;
moderate [0.5 to <0.8; large [0.8) Significant changes are indicated with an asterix (Fisher’s permutation test, ∗p<0.05, ∗∗p<0.01,
∗∗∗p<0.001). Trends (p<0.10) are shown as §.
Hospital Anxiety and Depression scale (HAD) ill patients.39 Ratings are summed for each of the
subscales yielding a range of scores reflecting severityThe HAD is a 14-item questionnaire designed for
screening for clinically significant psychological dis- of emotional disorder from 0 to 21 (maximum distress).
Validation of the Swedish HAD is reported elsewhere.40tress (anxiety and depression subscales) in somatically
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Mood Adjective Check List (MACL) The magnitude of the changes in SRMs may be judged
in clinical terms against the criteria suggested byThe MACL is a composite measure of current mental
well-being.41 It consists of 38 adjectives describing Cohen:49 trivial (0 to <±0.2), small ([±0.2 to <±0.5),
moderate ([±0.5 to <±0.8), and large ([±0.8)mood and related feelings.
changes in perceived health.
General Health Rating Index, Current Health In comparisons with the healthy reference group,
(GHRI-CH) effect sizes for claudication were determined by cal-
Current Health, the main factor from the GHRI,42 is a culating the difference in dimension score between
measure of perceived current health status. The version claudicant and reference values, divided by the av-
used in this study comprises 9 items with ratings erage deviation of the two groups. The same criteria
summed to a single CH score.43 as above were used for interpreting effect size.
Life Satisfaction scale (LS)
This scale consists of 6 questions on satisfaction with
Resultsfamily, housing, private economy, work, leisure ac-
tivities and standard of living.44 A global LS score is
Intention-to-treat analyses were performed on the dataobtained by averaging the 6 item ratings.
available from the 171 patients who completed HRQL
questionnaires at follow-up. At baseline, no differencesGlobal indices: Quality of Life and Physical condition
were found between treatment groups on any HRQLGlobal ratings of current quality of life and physical
variable.condition were extracted from the EORTC QLQ-C30.45
Table 1 presents descriptive statistics of baseline
and follow-up HRQL scores for the three treatmentSymptoms and Complaints scale
groups. Measures are arranged along the hy-This study-specific scale comprises 9 items describing
pothesised continuum of disease impact on HRQL.common intermittent claudication-related symptoms
Results of analyses of 1 year change, expressed asand complaints. Based on scaling tests, separate scores
effect sizes, are summarized in Figures 2 and 3.are obtained for symptoms and complaints ex-
Figure 2 shows within-group change, while Figureperienced while resting and while walking.
3 shows the HRQL dimensions with significant
between-group differences.
Ethics
Disease-specific symptoms and complaintsInformed consent was obtained from all patients. The
study was approved by the Committee for Ethics in
WalkMedical Investigations, Sahlgrenska University Hos-
Improvement in walk-related symptoms and com-pital, Go¨teborg University.
plaints was found only for the invasive therapy group
(p<0.001). This improvement was significantly greater
(p<0.01) than both no treatment and training.
Statistical methods
Rest
Analyses were performed on an intention-to-treat Improvement from baseline was found only for the
basis, including all patients having QoL data at follow- invasive therapy group (p<0.05). Invasive therapy
up. Comparisons among the three treatment groups proved more effective in alleviating rest symptoms
were conducted using Kruskal–Wallis non-parametric than no treatment (p<0.05).
analysis of variance (ANOVA)46 and Fisher’s dis-
tribution-free permutation test47 was used for between-
and within-group group comparisons. A 5% sig-
nificance level was used in all analyses. Functional health
HRQL mean change scores from baseline to follow-
up were transformed to standardised response means48 Physical functioning/mobility
Scores on the intermittent claudication-specific SIP(SRM=mean change between assessments divided by
the standard deviation of change) to enable com- scale, SIPIC, improved in the invasive therapy group
(p<0.05). Between group comparisons yielded greaterparisons of effect sizes in HRQL across instruments.
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Fig. 3. Health related quality of life dimensions differing significantly between treatment groups. Changes between baseline and follow-
up for the three treatment procedures are expressed as standardised response means (SRM=mean change between assessments divided
by the standard deviation of change; trivial <0.2; small [0.2 to <0.5; moderate [0.5 to <0.8; large [0.8). Significant changes between
groups are indicated with an asterix (Fisher’s permutation test, ∗p<0.05, ∗∗p<0.01).
improvement for invasive therapy than either control the control group after one year, while improvements
were seen for invasive therapy (p<0.001 and p<0.05,or training (p<0.05).
Invasive therapy improved scores (p<0.05) on SIP respectively) and for training regarding physical con-
dition (p<0.05). The only statistically significant dif-Ambulation, Sleep and rest and Recreation and pas-
times, while training produced improvements only on ference between treatment modalities was found
between invasive therapy and control in relation toRecreation and pastimes. In contrast, controls showed
no significant change on any category. Body care and current health (p<0.01).
movement deteriorated for the training (p<0.01) and
control groups (p<0.05). Controls also deteriorated on
Sleep and rest (p<0.05).
Mental health/Well-beingBetween group analyses showed invasive therapy
superior to no treatment for Sleep and rest (p<0.05)
Depression/Anxietyand Recreation and pastimes (p<0.05). Training was
No significant differences were found for either HADsuperior to no treatment on Recreation and pastimes
anxiety or depression between or within groups.(p<0.05).
Well-beingEmotional/cognitive/social functioning
Change in overall well-being (MACL) was trivial andNo significant changes in scores on SIP Emotional
non-significant in all groups at one year.behaviour, Social interaction, Alertness behaviour or
Psychosocial dimension were observed within or be-
tween any treatment groups.
Overall QoL
Significant improvement was observed only in theGeneral health
invasive therapy group (p<0.05), however, this change
was small and did not differ significantly from that ofAverage assessments of perceived current health and
physical condition remained virtually unchanged in either the training or control group.
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Life satisfaction from reference values (Fig. 5). Clinically large effects
([0.8) of claudication remained for SIP Ambulation,
Ratings on this scale increased in all groups at follow- Physical index, Overall SIP, SIPIC and Home man-
agement in all treatment groups. Magnitudes of theseup. The greatest improvement was observed following
invasive therapy (p<0.05). No significant differences differences from reference values were generally least
for invasive therapy, followed by training and largestwere found between groups.
for controls.
DiscussionEffect sizes: Strength of evidence
The relative efficacy of procedures for the treatmentMagnitudes of change (SRMs) in HRQL dimensions
of intermittent claudication is contentious. Studies re-were generally below±0.2, indicating trivial change in
lying on surrogate outcome measures have yieldedHRQL (Fig. 2). In the control group only 3 dimensions
conflicting results and HRQL studies have to date onlyexceeded this cut-off (all deterioration). Training pro-
established the benefits of treatment (either angio-duced small SRMs ([0.2 to <0.5) on 4 HRQL di-
plasty and surgery or physical training) over no treat-mensions, of which two represented improvement.
ment in selected groups of patients. The presentModerate SRMs ([0.5 to <0.8) were noted for only
randomized study was designed to evaluate the rel-invasive therapy (walk-related symptoms and Current
ative impacts at one-year of two treatment modalitieshealth). Otherwise, invasive therapy yielded primarily
(invasive therapy versus physical training) versus nosmall changes in HRQL.
treatment on unselected claudicants’ HRQL.Consistent with the hypothesised continuum of dis-
Confirming results from previous research, clau-ease impacts on health perceptions, the largest treat-
dicants reported substantial impairments in daily func-ment effect sizes (SRM[0.5) were seen in relation to
tional health compared with a healthy reference group.disease-specific symptoms and complaints, as well as
In line with the hypothesised continuum of illnessclaudication-related functional health (SIPIC and SIP
impacts on HRQL, significant limitations included aAmbulation). Also as expected, emotional, cognitive
wide range of functional behaviours either directly orand social functioning as well as mental health and
indirectly related to claudication symptoms, whilewell-being were unaffected (SRM<0.2) by treatment.
negligible effects of the illness were observed on men-However, comparatively large changes (SRM[0.2)
tal health, well-being, and emotional and cognitivewere witnessed in current health perceptions, overall
aspects of HRQL. A self-evident implication of theseQoL and life satisfaction, while small changes were
findings for evaluating treatment effects on HRQL isseen in the SIP category Mobility, SIP Physical index
that expectations for improvements should beand Overall SIP.
restrictive; all aspects of HRQL do not have equal
margins for improvement.
Results from this study also confirm the relatively
benign natural course of intermittent claudication inReference group comparisons
HRQL terms. At one year follow-up, untreated clau-
dicants witnessed no significant deterioration on mostBaseline and follow-up HRQL values were related to
those available from a healthy reference group. Figure HRQL measures from baseline. Significant declines in
daily physical functioning (SIP Body care and move-4 shows the effect size of claudication on HRQL di-
mensions at baseline. Compared with the reference ment and Sleep and rest) were not associated with
behaviours limited directly by intermittent clau-group, claudicants had worse ratings on all but two
HRQL dimensions (HAD anxiety and mental well- dication, but rather with limitations likely resulting
from the general effects of ageing or other concomitantbeing) at baseline. Differences were most pronounced
([0.8) for SIP Ambulation, Physical index, Overall SIP, illnesses (data not shown).
Supervised physical training produced significantSIPIC and Home management. Variation from reference
values was least (<0.5) for mental health (HAD), Well- improvements from baseline in only two HRQL do-
mains (SIP Recreation and pastimes and the single-being (MACL) and SIP Alertness as well as for prim-
arily emotional, cognitive and psychosocial func- item rating scale Physical condition) and an ambiguous
pattern of positive and negative trends were observedtioning SIP categories.
At follow-up, all dimensions strongly impacted on in others. Unexpectedly, deterioration was most strik-
ing in functional health, where reductions appearedby claudication at baseline still differed substantially
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Fig. 4. Health related quality of life comparisons between reference and claudicants’ values at baseline. Differences are expressed as effect
sizes (mean difference between groups divided by the average standard deviation: trivial <0.2; small [0.2 to <0.5; moderate [0.5 to
<0.8; large [0.8).
Fig. 5. Health related quality of life comparisons between reference and treatment group values for selected variables at follow-up.
Differences are expressed as effect sizes (mean difference between groups divided by the average standard deviation: trivial <0.2; small
[0.2 to <0.5; moderate [0.5 to <0.8; large [0.8).
in 10 of 15 SIP categories. Compared with no treatment, and pastimes. Improvement in this category, however,
may possibly be accounted for by the opportunitiesphysical training produced significantly greater im-
provement on only one HRQL category, SIP Recreation for increased leisure activity afforded by participation
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in the ongoing training programme. Our results for debilitating chronic illnesses among claudicants,50 such
as hypertension and diabetes mellitus.training contrast with those of Regensteiner et al.7 who
Health assessments may be expert-based (e.g. by afound significantly improved physical functioning in
physician) or patient-based, both perspectives onpatients undergoing supervised physical training com-
health merit study in their own right. Expert-basedpared with an untreated group. A possible explanation
assessments are important in defining the patient’sfor this inconsistency is that our patient group was
state of organic health, while patient-based as-unselected, thus including patients with severe clau-
sessments reflect how the patient experiences his/dication who were perhaps not optimal candidates for
her health. These two perspectives are not entirelyphysical training. In contrast, the patient group in the
consistent,51 but rather provide complementary in-latter study consisted of a comparatively small number
formation on a patient’s health status. In evaluatingof patients (n=29) selected on the basis of their ability
treatments, surrogate markers, such as blood flowto benefit from training.
measures and treadmill performance, serve as in-Invasive therapies were shown to produce sig-
dicators of the degree to which physical prerequisitesnificant increments in a broad range of HRQL domains.
for patient-experienced improvement are fulfilled. Ul-In line with previous research, invasive therapies were
timately, however, success of treatment must be judgedfound to yield significantly greater HRQL benefits
against the patient’s own assessments of change inthan no treatment in relation to patient-perceived
various aspects of everyday life affected by the illness.symptomatic relief and aspects of functional health
(SIPIC, SIP Sleep and rest and SIP Recreation and
pastimes). Perception of current health (GHRI-CH)
was also significantly better in this group than in the Conclusions
untreated patient group. Also consistent with earlier
Results suggest that invasive therapy is more effectivestudies, other HRQL modalities (e.g. mental health,
than supervised training in alleviating illness-specificwell-being, overall quality of life) were not sig-
symptoms and improving certain aspects of physicalnificantly affected by mode of treatment.
functioning – the primary HRQL domains impactedThis study is unique in undertaking direct com-
on by IC and the principal goals of its treatment.parisons of impacts on HRQL of invasive therapies
However, since average treatment effect sizes were atversus supervised physical training, and in doing so,
most moderate and given that on average untreatedusing an unselected patient group with different de-
claudicants reported at most small deterioration ingrees of disease severity. The data point to the su-
HRQL after one year, in the short-term the level ofperiority of invasive therapies over training in
evidence supporting invasive therapy is modest. Largeimproving walk-related symptoms and behavioural
inter-individual variation in HRQL outcomes suggestslimitations commonly associated with the disease
the need for further long-term research aimed at de-(SIPIC), and the general pattern across nearly all HRQL termining outcome predictors of treatment proceduresdimensions also favoured invasive therapies. It is im-
for IC.portant to note, however, that even when statistically
significant differences were found, magnitudes of
change (effect sizes) were within a small-to-moderate
range, corroborating magnitudes found six months Acknowledgements
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